Cipla Technologies, Pulmatrix agree for development and commercialization of Pulmazole
Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America
Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh
The company has received five final approvals
Sirius JV will be owned 51% by Sirius and 49% by Adani
Subscribe To Our Newsletter & Stay Updated